NEW YORK (GenomeWeb) – Interpace Diagnostics announced today that its Medicare administrative carrier Novitas Solutions has issued a positive coverage decision for the company's ThyraMir microRNA classifier, which is used in conjunction with its ThyGenX oncogene panel to assess fine needle aspiration (FNA) samples from indeterminate thyroid nodules.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.